Below are four recent long COVID-19 updates Becker's has covered since the beginning of 2023:
- The CDC awarded Helix a new contract to research how genetics affect COVID-19 vaccine efficacy. The research, according to Daniel Lee, Helix's senior vice president of life sciences and growth, will provide new insight into the adverse effects of long COVID-19.
- A recent study looking at the duration of symptoms from long COVID-19 highlighted that while a majority of symptoms ease within one year, others, specifically loss of taste and smell, have been found to last longer.
- New research led by Stephanie Richard, PhD, Simon Pollett, and Anthony Fries, PhD, unveiled that vaccination — even after the onset of COVID-19 infection — lowers risk factors associated with long COVID-19, including risk for pulmonary, diabetes, neurological and mental health encounters.
- The effects of long COVID-19 are now being felt across the U.S. workforce, according to a Jan. 24 report from the New York State Insurance Fund. Of the 3,139 COVID-19-related compensation claims the fund examined, 31 percent involved individuals with long COVID-19.